HHLR ADVISORS, LTD. BBIO Holdings History
HHLR ADVISORS, LTD.'s BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, HHLR ADVISORS, LTD. held - shares of BridgeBio Pharma Inc(BBIO), totaling N/A. This investment constitutes 0% of their stock portfolio, and HHLR ADVISORS, LTD. now holds 0% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2019Q2. And since then HHLR ADVISORS, LTD. has made 5 purchases of BBIO, at an average price of $32.28, for a total of 5.39 Mil shares. In addition, there have been 8 sales at an average price of $22.90 for 5.39 Mil shares. Based on historical transaction data and BBIO's current price of $46.51, HHLR ADVISORS, LTD.'s estimated gain on his BBIO holdings is $-50.50 Mil, reflecting a -29.05% gain to date.
HHLR ADVISORS, LTD. BBIO ($46.51) Holding Chart
HHLR ADVISORS, LTD. BBIO ($46.51) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
